WEARABLE-DETECTED ATRIAL FIBRILLATION ALERTS: CLINICAL YIELD, PSYCHOLOGICAL BURDEN, EQUITY, AND HEALTH-SYSTEM CONSEQUENCES - A STRUCTURED REVIEW

Radoslaw Sciepuro; Dawid  Cyls; Marta Czarnowska; Nina Czarnowska

doi:10.31435/ijitss.3(51).2026.6308

Authors

Radoslaw Sciepuro Ludwik Rydygier Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland https://orcid.org/0009-0006-6430-4398
Dawid Cyls 10th Military Clinical Hospital with Polyclinic in Bydgoszcz, 5 Powstańców Warszawy Street, 85-681 Bydgoszcz, Poland https://orcid.org/0000-0002-5732-2655
Marta Czarnowska Ludwik Rydygier Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland https://orcid.org/0009-0002-4547-2098
Nina Czarnowska Nicolaus Copernicus University, Toruń, Poland https://orcid.org/0009-0003-0149-8955

DOI:

https://doi.org/10.31435/ijitss.3(51).2026.6308

Keywords:

Atrial Fibrillation; Wearable Devices; Screening; Overdiagnosis; Health Anxiety; Health Care Utiliza-Tion

Abstract

Background: Consumer smartwatches and wearable electrocardiographic monitors have moved part of atrial fibrillation (AF) screening into continuous, patient-initiated surveillance.

Objective: To evaluate wearable-enabled AF detection in relation to diagnostic yield, clinical outcomes, overdiagnosis, psychological effects, health care utilization, equity, and governance.

Materials and Methods: PubMed/MEDLINE was searched, with supplementary citation and guideline tracking. Twenty-nine publications were included in a structured narrative synthesis.

Results: Large consumer-device studies found that irregular-rhythm notifications were un-common, and subsequent AF confirmation varied with device type, timing, and baseline risk. Randomized screening trials generally increased AF detection and anticoagulant initiation, but most did not demonstrate reductions in stroke, mortality, or hospitalization. Supported monitor-ing programs usually did not increase anxiety, whereas observational studies of routine weara-ble use identified greater symptom preoccupation, treatment concern, clinician contact, and di-agnostic activity. Consumer ownership and digital capability may also reproduce existing ine-qualities in access.

Conclusions: A photoplethysmographic alert should initiate risk assessment and electrocardiographic confirmation rather than be treated as a diagnosis or an indication for therapy. Clinical value is more likely when screening is targeted, follow-up responsibility is ex-plicit, communication reduces uncertainty, and programs evaluate patient-important outcomes, workload, and equity alongside detection yield.

References

Belani, S., Wahood, W., Hardigan, P., Placzek, A. N., & Ely, S. (2021). Accuracy of detecting atrial fibrillation: A systematic review and meta-analysis of wrist-worn wearable technology. Cureus, 13(12), e20362. https://doi.org/10.7759/cureus.20362

Chandrasekaran, R., Katthula, V., & Moustakas, E. (2020). Patterns of use and key predictors for the use of wearable health care devices by US adults: Insights from a national survey. Journal of Medical Internet Research, 22(10), e22443. https://doi.org/10.2196/22443

Chen, W., Khurshid, S., Singer, D. E., Atlas, S. J., Ashburner, J. M., Ellinor, P. T., McManus, D. D., Lubitz, S. A., & Chhatwal, J. (2022). Cost-effectiveness of screening for atrial fibrillation using wearable devices. JAMA Health Forum, 3(8), e222419. https://doi.org/10.1001/jamahealthforum.2022.2419

Ding, E. Y., Tran, K. V., Lessard, D., Wang, Z., Han, D., Mohagheghian, F., Mensah Otabil, E., Noorishirazi, K., Mehawej, J., Filippaios, A., Naeem, S., Gottbrecht, M. F., Fitzgibbons, T. P., Saczynski, J. S., Barton, B., Chon, K., & McManus, D. D. (2023). Accuracy, usability, and adherence of smartwatches for atrial fibrillation detection in older adults after stroke: Randomized controlled trial. JMIR Cardio, 7, e45137. https://doi.org/10.2196/45137

Fabritz, L., Connolly, D. L., Czarnecki, E., Dudek, D., Guasch, E., Haase, D., Huebner, T., Zlahoda-Huzior, A., Jolly, K., Kirchhof, P., Obergassel, J., Schotten, U., Vettorazzi, E., Winkelmann, S. J., Zapf, A., Schnabel, R. B., & Smart in OAC—AFNET 9 Investigators. (2022). Smartphone- and wearable-detected atrial arrhythmias in older adults: Results of a fully digital European case-finding study. European Heart Journal - Digital Health, 3(4), 610–625. https://doi.org/10.1093/ehjdh/ztac067

Gladstone, D. J., Wachter, R., Schmalstieg-Bahr, K., Quinn, F. R., Hummers, E., Ivers, N., Marsden, T., Thornton, A., Djuric, A., Suerbaum, J., von Grünhagen, D., McIntyre, W. F., Benz, A. P., Wong, J. A., Merali, F., Henein, S., Nichol, C., Connolly, S. J., Healey, J. S., & SCREEN-AF Investigators and Coordinators. (2021). Screening for atrial fibrillation in the older population: A randomized clinical trial. JAMA Cardiology, 6(5), 558–567. https://doi.org/10.1001/jamacardio.2021.0038

Guo, Y., Wang, H., Zhang, H., Chen, Y., & Lip, G. Y. H. (2020). Population-based screening or targeted screening based on initial clinical risk assessment for atrial fibrillation: A report from the Huawei Heart Study. Journal of Clinical Medicine, 9(5), 1493. https://doi.org/10.3390/jcm9051493

Haase, C. B., Jensen, A. E., Modin, F. A., Siersma, V., & Brodersen, J. B. (2026). Overdiagnosis in atrial fibrillation screening with wearables. Scandinavian Journal of Primary Health Care, 44(1), 2656694. https://doi.org/10.1080/02813432.2026.2656694

Halcox, J. P. J., Wareham, K., Cardew, A., Gilmore, M., Barry, J. P., Phillips, C., & Gravenor, M. B. (2017). Assessment of remote heart rhythm sampling using the AliveCor Heart Monitor to screen for atrial fibrillation: The REHEARSE-AF study. Circulation, 136(19), 1784–1794. https://doi.org/10.1161/CIRCULATIONAHA.117.030583

Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., Gorenek, B., Hess, P. L., Hlatky, M., Hogan, G., Ibeh, C., Indik, J. H., Kido, K., Kusumoto, F., Link, M. S., . . . Peer Review Committee Members. (2024). 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 149(1), e1–e156. https://doi.org/10.1161/CIR.0000000000001193

Lopes, R. D., Atlas, S. J., Go, A. S., Lubitz, S. A., McManus, D. D., Dolor, R. J., Chatterjee, R., Rothberg, M. B., Rushlow, D. R., Crosson, L. A., Aronson, R. S., Patlakh, M., Gallup, D., Mills, D. J., O’Brien, E. C., & Singer, D. E. (2024). Effect of screening for undiagnosed atrial fibrillation on stroke prevention. Journal of the American College of Cardiology, 84(21), 2073–2084. https://doi.org/10.1016/j.jacc.2024.08.019

Lubitz, S. A., Faranesh, A. Z., Selvaggi, C., Atlas, S. J., McManus, D. D., Singer, D. E., Pagoto, S., McConnell, M. V., Pantelopoulos, A., & Foulkes, A. S. (2022). Detection of atrial fibrillation in a large population using wearable devices: The Fitbit Heart Study. Circulation, 146(19), 1415–1424. https://doi.org/10.1161/CIRCULATIONAHA.122.060291

Lubitz, S. A., Atlas, S. J., Ashburner, J. M., Lipsanopoulos, A. T. T., Borowsky, L. H., Guan, W., Khurshid, S., Ellinor, P. T., Chang, Y., McManus, D. D., & Singer, D. E. (2022). Screening for atrial fibrillation in older adults at primary care visits: VITAL-AF randomized controlled trial. Circulation, 145(13), 946–954. https://doi.org/10.1161/CIRCULATIONAHA.121.057014

Paul, T. J., Tran, K. V., Mehawej, J., Lessard, D., Ding, E., Filippaios, A., Howard-Wilson, S., Otabil, E. M., Noorishirazi, K., Naeem, S., Hamel, A., Han, D., Chon, K. H., Barton, B., Saczynski, J., & McManus, D. (2023). Anxiety, patient activation, and quality of life among stroke survivors prescribed smartwatches for atrial fibrillation monitoring. Cardiovascular Digital Health Journal, 4(4), 118–125. https://doi.org/10.1016/j.cvdhj.2023.04.002

Perez, M. V., Mahaffey, K. W., Hedlin, H., Rumsfeld, J. S., Garcia, A., Ferris, T., Balasubramanian, V., Russo, A. M., Rajmane, A., Cheung, L., Hung, G., Lee, J., Kowey, P., Talati, N., Nag, D., Gummidipundi, S. E., Beatty, A., Hills, M. T., Desai, S., . . . Apple Heart Study Investigators. (2019). Large-scale assessment of a smartwatch to identify atrial fibrillation. The New England Journal of Medicine, 381(20), 1909–1917. https://doi.org/10.1056/NEJMoa1901183

Prasitlumkum, N., Cheungpasitporn, W., Chokesuwattanaskul, A., Thangjui, S., Thongprayoon, C., Bathini, T., Vallabhajosyula, S., Kanitsoraphan, C., Leesutipornchai, T., & Chokesuwattanaskul, R. (2021). Diagnostic accuracy of smart gadgets/wearable devices in detecting atrial fibrillation: A systematic review and meta-analysis. Archives of Cardiovascular Diseases, 114(1), 4–16. https://doi.org/10.1016/j.acvd.2020.05.015

Predel, C., & Steger, F. (2020). Ethical challenges with smartwatch-based screening for atrial fibrillation: Putting users at risk for marketing purposes? Frontiers in Cardiovascular Medicine, 7, 615927. https://doi.org/10.3389/fcvm.2020.615927

Rizas, K. D., Freyer, L., Sappler, N., von Stülpnagel, L., Spielbichler, P., Krasniqi, A., Schreinlechner, M., Wenner, F. N., Theurl, F., Behroz, A., Eiffener, E., Klemm, M. P., Schneidewind, A., Zens, M., Dolejsi, T., Mansmann, U., Massberg, S., & Bauer, A. (2022). Smartphone-based screening for atrial fibrillation: A pragmatic randomized clinical trial. Nature Medicine, 28(9), 1823–1830. https://doi.org/10.1038/s41591-022-01979-w

Rosman, L., Lampert, R., Zhuo, S., Li, Q., Varma, N., Burg, M., Gaffey, A. E., Armbruster, T., & Gehi, A. (2024). Wearable devices, health care use, and psychological well-being in patients with atrial fibrillation. Journal of the American Heart Association, 13(15), e033750. https://doi.org/10.1161/JAHA.123.033750

Sandberg, E. L., Halvorsen, S., Berge, T., Grimsmo, J., Atar, D., Fensli, R., Grenne, B. L., & Jortveit, J. (2023). Fully digital self-screening for atrial fibrillation with patch electrocardiogram. Europace, 25(5), euad075. https://doi.org/10.1093/europace/euad075

Steinhubl, S. R., Waalen, J., Edwards, A. M., Ariniello, L. M., Mehta, R. R., Ebner, G. S., Carter, C., Baca-Motes, K., Felicione, E., Sarich, T., & Topol, E. J. (2018). Effect of a home-based wearable continuous ECG monitoring patch on detection of undiagnosed atrial fibrillation: The mSToPS randomized clinical trial. JAMA, 320(2), 146–155. https://doi.org/10.1001/jama.2018.8102

Svendsen, J. H., Diederichsen, S. Z., Højberg, S., Krieger, D. W., Graff, C., Kronborg, C., Olesen, M. S., Nielsen, J. B., Holst, A. G., Brandes, A., Haugan, K. J., & Køber, L. (2021). Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): A randomised controlled trial. The Lancet, 398(10310), 1507–1516. https://doi.org/10.1016/S0140-6736(21)01698-6

Svennberg, E., Friberg, L., Frykman, V., Al-Khalili, F., Engdahl, J., & Rosenqvist, M. (2021). Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): A multicentre, parallel-group, unmasked, randomised controlled trial. The Lancet, 398(10310), 1498–1506. https://doi.org/10.1016/S0140-6736(21)01637-8

Tison, G. H., Sanchez, J. M., Ballinger, B., Singh, A., Olgin, J. E., Pletcher, M. J., Vittinghoff, E., Lee, E. S., Fan, S. M., Gladstone, R. A., Mikell, C., Sohoni, N., Hsieh, J., & Marcus, G. M. (2018). Passive detection of atrial fibrillation using a commercially available smartwatch. JAMA Cardiology, 3(5), 409–416. https://doi.org/10.1001/jamacardio.2018.0136

US Preventive Services Task Force, Davidson, K. W., Barry, M. J., Mangione, C. M., Cabana, M., Caughey, A. B., Davis, E. M., Donahue, K. E., Doubeni, C. A., Epling, J. W., Kubik, M., Li, L., Ogedegbe, G., Pbert, L., Silverstein, M., Stevermer, J., Tseng, C. W., & Wong, J. B. (2022). Screening for atrial fibrillation: US Preventive Services Task Force recommendation statement. JAMA, 327(4), 360–367. https://doi.org/10.1001/jama.2021.23732

Wahab, A., Nadarajah, R., Larvin, H., Farooq, M., Raveendra, K., Haris, M., Nadeem, U., Joseph, T., Bhatty, A., Wilkinson, C., Khunti, K., Vedanthan, R., Camm, A. J., Svennberg, E., Lip, G. Y., Freedman, B., Wu, J., & Gale, C. P. (2025). Systematic screening for atrial fibrillation with non-invasive devices: A systematic review and meta-analysis. The Lancet Regional Health - Europe, 53, 101298. https://doi.org/10.1016/j.lanepe.2025.101298

Wang, L., Nielsen, K., Goldberg, J., Brown, J. R., Rumsfeld, J. S., Steinberg, B. A., Zhang, Y., Matheny, M. E., & Shah, R. U. (2021). Association of wearable device use with pulse rate and health care use in adults with atrial fibrillation. JAMA Network Open, 4(5), e215821. https://doi.org/10.1001/jamanetworkopen.2021.5821

Wijesurendra, R., Pessoa-Amorim, G., Buck, G., Harper, C., Bulbulia, R., Offer, A., Jones, N. R., A'Court, C., Kurien, R., Taylor, K., Casadei, B., & Bowman, L. (2025). Remote screening for asymptomatic atrial fibrillation: The AMALFI randomized clinical trial. JAMA, 334(15), 1349–1357. https://doi.org/10.1001/jama.2025.15440

Wyatt, K. D., Poole, L. R., Mullan, A. F., Kopecky, S. L., & Heaton, H. A. (2020). Clinical evaluation and diagnostic yield following evaluation of abnormal pulse detected using Apple Watch. Journal of the American Medical Informatics Association, 27(9), 1359–1363. https://doi.org/10.1093/jamia/ocaa137